25 XP   0   0   10

AJANTA PHARMA LTD.
Buy, Hold or Sell?

Let's analyse AJANTA PHARMA LTD. together

PenkeI guess you are interested in AJANTA PHARMA LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of AJANTA PHARMA LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about AJANTA PHARMA LTD.

I send you an email if I find something interesting about AJANTA PHARMA LTD..

Quick analysis of AJANTA PHARMA LTD. (30 sec.)










What can you expect buying and holding a share of AJANTA PHARMA LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.34
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR269.07
Expected worth in 1 year
INR335.27
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR94.70
Return On Investment
4.6%

For what price can you sell your share?

Current Price per Share
INR2,079.70
Expected price per share
INR1,922 - INR2,276
How sure are you?
50%

1. Valuation of AJANTA PHARMA LTD. (5 min.)




Live pricePrice per Share (EOD)

INR2,079.70

Intrinsic Value Per Share

INR543.32 - INR793.67

Total Value Per Share

INR812.39 - INR1,062.73

2. Growth of AJANTA PHARMA LTD. (5 min.)




Is AJANTA PHARMA LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$406.5m$391.7m$14.8m3.6%

How much money is AJANTA PHARMA LTD. making?

Current yearPrevious yearGrowGrow %
Making money$70.5m$85.5m-$14.9m-21.2%
Net Profit Margin15.7%21.3%--

How much money comes from the company's main activities?

3. Financial Health of AJANTA PHARMA LTD. (5 min.)




What can you expect buying and holding a share of AJANTA PHARMA LTD.? (5 min.)

Welcome investor! AJANTA PHARMA LTD.'s management wants to use your money to grow the business. In return you get a share of AJANTA PHARMA LTD..

What can you expect buying and holding a share of AJANTA PHARMA LTD.?

First you should know what it really means to hold a share of AJANTA PHARMA LTD.. And how you can make/lose money.

Speculation

The Price per Share of AJANTA PHARMA LTD. is INR2,080. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of AJANTA PHARMA LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in AJANTA PHARMA LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR269.07. Based on the TTM, the Book Value Change Per Share is INR16.55 per quarter. Based on the YOY, the Book Value Change Per Share is INR21.72 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR7.12 per quarter.
Based on historical numbers we can estimate the returns while holding a share of AJANTA PHARMA LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.560.0%0.560.0%0.660.0%0.530.0%0.500.0%
Usd Book Value Change Per Share0.200.0%0.200.0%0.260.0%0.260.0%0.400.0%
Usd Dividend Per Share0.090.0%0.090.0%0.080.0%0.080.0%0.080.0%
Usd Total Gains Per Share0.280.0%0.280.0%0.340.0%0.340.0%0.480.0%
Usd Price Per Share14.53-14.53-26.82-17.38-17.77-
Price to Earnings Ratio25.92-25.92-40.55-32.75-36.06-
Price-to-Total Gains Ratio51.13-51.13-79.60-52.57-45.11-
Price to Book Ratio4.50-4.50-8.85-6.36-8.68-
Price-to-Total Gains Ratio51.13-51.13-79.60-52.57-45.11-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share24.9564
Number of shares40
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.090.08
Usd Book Value Change Per Share0.200.26
Usd Total Gains Per Share0.280.34
Gains per Quarter (40 shares)11.3613.64
Gains per Year (40 shares)45.4654.57
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1143235144145
22764802782100
3419512541123155
45512717054164210
56815921568205265
68219126081246320
79622230595287375
8109254350108329430
9123286395122370485
10137318440135411540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%

Fundamentals of AJANTA PHARMA LTD.

About AJANTA PHARMA LTD.

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as antimalarial, cardiology, ophthalmology, dermatology, pain management, gastroenterology, antihistamine, respiratory, diabetes areas. It also provides tablets, capsules, powder, liquid, jelly, ointments, sterile eye drops, active pharma ingredient. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

Fundamental data was last updated by Penke on 2024-04-13 20:06:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of AJANTA PHARMA LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit AJANTA PHARMA LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 15.7% means that ₹0.16 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of AJANTA PHARMA LTD.:

  • The MRQ is 15.7%. The company is making a huge profit. +2
  • The TTM is 15.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ15.7%TTM15.7%0.0%
TTM15.7%YOY21.3%-5.6%
TTM15.7%5Y19.3%-3.6%
5Y19.3%10Y21.0%-1.6%
1.1.2. Return on Assets

Shows how efficient AJANTA PHARMA LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 12.6% Return on Assets means that AJANTA PHARMA LTD. generated ₹0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of AJANTA PHARMA LTD.:

  • The MRQ is 12.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 12.6%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ12.6%TTM12.6%0.0%
TTM12.6%YOY17.6%-5.0%
TTM12.6%5Y15.2%-2.6%
5Y15.2%10Y18.8%-3.6%
1.1.3. Return on Equity

Shows how efficient AJANTA PHARMA LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • 17.4% Return on Equity means AJANTA PHARMA LTD. generated ₹0.17 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of AJANTA PHARMA LTD.:

  • The MRQ is 17.4%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 17.4%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ17.4%TTM17.4%0.0%
TTM17.4%YOY21.8%-4.5%
TTM17.4%5Y19.2%-1.9%
5Y19.2%10Y23.3%-4.1%

1.2. Operating Efficiency of AJANTA PHARMA LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient AJANTA PHARMA LTD. is operating .

  • Measures how much profit AJANTA PHARMA LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 17.9% means the company generated ₹0.18  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of AJANTA PHARMA LTD.:

  • The MRQ is 17.9%. The company is operating efficient. +1
  • The TTM is 17.9%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ17.9%TTM17.9%0.0%
TTM17.9%YOY24.6%-6.7%
TTM17.9%5Y24.0%-6.1%
5Y24.0%10Y22.5%+1.5%
1.2.2. Operating Ratio

Measures how efficient AJANTA PHARMA LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.12 means that the operating costs are ₹1.12 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of AJANTA PHARMA LTD.:

  • The MRQ is 1.124. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.124. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.124TTM1.1240.000
TTM1.124YOY1.005+0.119
TTM1.1245Y1.010+0.114
5Y1.01010Y0.895+0.116

1.3. Liquidity of AJANTA PHARMA LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if AJANTA PHARMA LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.48 means the company has ₹2.48 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of AJANTA PHARMA LTD.:

  • The MRQ is 2.480. The company is able to pay all its short-term debts. +1
  • The TTM is 2.480. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.480TTM2.4800.000
TTM2.480YOY3.498-1.018
TTM2.4805Y2.987-0.507
5Y2.98710Y3.107-0.120
1.3.2. Quick Ratio

Measures if AJANTA PHARMA LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.11 means the company can pay off ₹2.11 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of AJANTA PHARMA LTD.:

  • The MRQ is 2.113. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.113. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.113TTM2.1130.000
TTM2.113YOY2.271-0.158
TTM2.1135Y2.063+0.050
5Y2.06310Y2.282-0.219

1.4. Solvency of AJANTA PHARMA LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of AJANTA PHARMA LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare AJANTA PHARMA LTD. to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.28 means that AJANTA PHARMA LTD. assets are financed with 27.6% credit (debt) and the remaining percentage (100% - 27.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of AJANTA PHARMA LTD.:

  • The MRQ is 0.276. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.276. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.276TTM0.2760.000
TTM0.276YOY0.195+0.081
TTM0.2765Y0.212+0.063
5Y0.21210Y0.197+0.015
1.4.2. Debt to Equity Ratio

Measures if AJANTA PHARMA LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 38.1% means that company has ₹0.38 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of AJANTA PHARMA LTD.:

  • The MRQ is 0.381. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.381. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.381TTM0.3810.000
TTM0.381YOY0.242+0.139
TTM0.3815Y0.273+0.109
5Y0.27310Y0.249+0.024

2. Market Valuation of AJANTA PHARMA LTD.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings AJANTA PHARMA LTD. generates.

  • Above 15 is considered overpriced but always compare AJANTA PHARMA LTD. to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 25.92 means the investor is paying ₹25.92 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of AJANTA PHARMA LTD.:

  • The EOD is 44.537. Based on the earnings, the company is overpriced. -1
  • The MRQ is 25.924. Based on the earnings, the company is overpriced. -1
  • The TTM is 25.924. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD44.537MRQ25.924+18.613
MRQ25.924TTM25.9240.000
TTM25.924YOY40.546-14.622
TTM25.9245Y32.747-6.823
5Y32.74710Y36.060-3.313
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of AJANTA PHARMA LTD.:

  • The EOD is 42.422. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 24.693. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 24.693. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD42.422MRQ24.693+17.729
MRQ24.693TTM24.6930.000
TTM24.693YOY69.933-45.240
TTM24.6935Y134.574-109.881
5Y134.57410Y270.779-136.205
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of AJANTA PHARMA LTD. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 4.50 means the investor is paying ₹4.50 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of AJANTA PHARMA LTD.:

  • The EOD is 7.729. Based on the equity, the company is overpriced. -1
  • The MRQ is 4.499. Based on the equity, the company is fair priced.
  • The TTM is 4.499. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD7.729MRQ4.499+3.230
MRQ4.499TTM4.4990.000
TTM4.499YOY8.852-4.353
TTM4.4995Y6.361-1.862
5Y6.36110Y8.679-2.318
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of AJANTA PHARMA LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--16.55216.5520%21.722-24%21.389-23%33.633-51%
Book Value Per Share--269.067269.0670%252.516+7%227.417+18%189.786+42%
Current Ratio--2.4802.4800%3.498-29%2.987-17%3.107-20%
Debt To Asset Ratio--0.2760.2760%0.195+41%0.212+30%0.197+40%
Debt To Equity Ratio--0.3810.3810%0.242+57%0.273+40%0.249+53%
Dividend Per Share--7.1237.1230%6.359+12%7.032+1%6.751+6%
Eps--46.69646.6960%55.130-15%44.016+6%41.319+13%
Free Cash Flow Per Share--49.02449.0240%31.963+53%26.391+86%20.079+144%
Free Cash Flow To Equity Per Share--40.45740.4570%-3.623+109%8.270+389%5.584+625%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--793.667--------
Intrinsic Value_10Y_min--543.321--------
Intrinsic Value_1Y_max--46.579--------
Intrinsic Value_1Y_min--33.807--------
Intrinsic Value_3Y_max--165.064--------
Intrinsic Value_3Y_min--120.052--------
Intrinsic Value_5Y_max--313.828--------
Intrinsic Value_5Y_min--225.886--------
Market Cap261867505200.000+42%152427613800.000152427613800.0000%288963128955.204-47%185105243467.498-18%188196288613.386-19%
Net Profit Margin--0.1570.1570%0.213-26%0.193-19%0.210-25%
Operating Margin--0.1790.1790%0.246-27%0.240-25%0.225-20%
Operating Ratio--1.1241.1240%1.005+12%1.010+11%0.895+26%
Pb Ratio7.729+42%4.4994.4990%8.852-49%6.361-29%8.679-48%
Pe Ratio44.537+42%25.92425.9240%40.546-36%32.747-21%36.060-28%
Price Per Share2079.700+42%1210.5501210.5500%2235.298-46%1448.079-16%1480.874-18%
Price To Free Cash Flow Ratio42.422+42%24.69324.6930%69.933-65%134.574-82%270.779-91%
Price To Total Gains Ratio87.845+42%51.13251.1320%79.600-36%52.571-3%45.112+13%
Quick Ratio--2.1132.1130%2.271-7%2.063+2%2.282-7%
Return On Assets--0.1260.1260%0.176-28%0.152-17%0.188-33%
Return On Equity--0.1740.1740%0.218-21%0.192-10%0.233-26%
Total Gains Per Share--23.67523.6750%28.082-16%28.422-17%40.384-41%
Usd Book Value--406558800.000406558800.0000%391720800.000+4%347808960.000+17%289379400.000+40%
Usd Book Value Change Per Share--0.1990.1990%0.261-24%0.257-23%0.404-51%
Usd Book Value Per Share--3.2293.2290%3.030+7%2.729+18%2.277+42%
Usd Dividend Per Share--0.0850.0850%0.076+12%0.084+1%0.081+6%
Usd Eps--0.5600.5600%0.662-15%0.528+6%0.496+13%
Usd Free Cash Flow--74074800.00074074800.0000%49584000.000+49%40424400.000+83%30681750.000+141%
Usd Free Cash Flow Per Share--0.5880.5880%0.384+53%0.317+86%0.241+144%
Usd Free Cash Flow To Equity Per Share--0.4850.4850%-0.043+109%0.099+389%0.067+625%
Usd Market Cap3142410062.400+42%1829131365.6001829131365.6000%3467557547.462-47%2221262921.610-18%2258355463.361-19%
Usd Price Per Share24.956+42%14.52714.5270%26.824-46%17.377-16%17.770-18%
Usd Profit--70557600.00070557600.0000%85522800.000-17%67421040.000+5%63004350.000+12%
Usd Revenue--449116800.000449116800.0000%400918800.000+12%350797440.000+28%307476450.000+46%
Usd Total Gains Per Share--0.2840.2840%0.337-16%0.341-17%0.485-41%
 EOD+4 -4MRQTTM+0 -0YOY+15 -205Y+19 -1610Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of AJANTA PHARMA LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1544.537
Price to Book Ratio (EOD)Between0-17.729
Net Profit Margin (MRQ)Greater than00.157
Operating Margin (MRQ)Greater than00.179
Quick Ratio (MRQ)Greater than12.113
Current Ratio (MRQ)Greater than12.480
Debt to Asset Ratio (MRQ)Less than10.276
Debt to Equity Ratio (MRQ)Less than10.381
Return on Equity (MRQ)Greater than0.150.174
Return on Assets (MRQ)Greater than0.050.126
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of AJANTA PHARMA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.103
Ma 20Greater thanMa 502,156.418
Ma 50Greater thanMa 1002,145.855
Ma 100Greater thanMa 2002,105.423
OpenGreater thanClose2,067.900
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets46,790,200
Total Liabilities12,910,300
Total Stockholder Equity33,879,900
 As reported
Total Liabilities 12,910,300
Total Stockholder Equity+ 33,879,900
Total Assets = 46,790,200

Assets

Total Assets46,790,200
Total Current Assets28,251,800
Long-term Assets18,450,200
Total Current Assets
Cash And Cash Equivalents 3,298,300
Short-term Investments 5,102,700
Net Receivables 10,569,000
Inventory 8,156,300
Other Current Assets 10,700
Total Current Assets  (as reported)28,251,800
Total Current Assets  (calculated)27,137,000
+/- 1,114,800
Long-term Assets
Property Plant Equipment 16,981,600
Intangible Assets 77,500
Other Assets 1,103,300
Long-term Assets  (as reported)18,450,200
Long-term Assets  (calculated)18,162,400
+/- 287,800

Liabilities & Shareholders' Equity

Total Current Liabilities11,392,800
Long-term Liabilities1,517,500
Total Stockholder Equity33,879,900
Total Current Liabilities
Short Long Term Debt 1,800
Accounts payable 4,227,700
Other Current Liabilities 6,930,600
Total Current Liabilities  (as reported)11,392,800
Total Current Liabilities  (calculated)11,160,100
+/- 232,700
Long-term Liabilities
Long term Debt Total 262,000
Long term Debt 12,500
Capital Lease Obligations Min Short Term Debt342,000
Long-term Liabilities Other 26,700
Long-term Liabilities  (as reported)1,517,500
Long-term Liabilities  (calculated)643,200
+/- 874,300
Total Stockholder Equity
Common Stock252,700
Retained Earnings 33,527,500
Other Stockholders Equity 96,300
Total Stockholder Equity (as reported)33,879,900
Total Stockholder Equity (calculated)33,876,500
+/- 3,400
Other
Capital Stock252,700
Cash and Short Term Investments 8,401,000
Common Stock Shares Outstanding 125,915
Liabilities and Stockholders Equity 46,790,200
Net Invested Capital 33,894,200
Net Working Capital 16,947,200
Property Plant and Equipment Gross 16,981,600



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
14,879,600
18,477,000
24,485,900
26,961,800
33,186,900
37,787,200
40,555,800
46,790,200
46,790,20040,555,80037,787,20033,186,90026,961,80024,485,90018,477,00014,879,600
   > Total Current Assets 
7,632,700
8,506,000
12,236,200
11,798,100
16,417,100
20,275,900
22,644,600
28,251,800
28,251,80022,644,60020,275,90016,417,10011,798,10012,236,2008,506,0007,632,700
       Cash And Cash Equivalents 
0
519,400
906,400
951,600
2,023,500
1,775,100
2,063,700
3,298,300
3,298,3002,063,7001,775,1002,023,500951,600906,400519,4000
       Short-term Investments 
0
1,815,600
1,848,300
647,400
671,400
2,006,700
1,218,600
5,102,700
5,102,7001,218,6002,006,700671,400647,4001,848,3001,815,6000
       Net Receivables 
3,723,500
3,281,200
5,726,700
5,493,700
7,753,000
7,384,300
10,198,100
10,569,000
10,569,00010,198,1007,384,3007,753,0005,493,7005,726,7003,281,2003,723,500
       Inventory 
2,073,300
2,110,200
3,506,300
4,357,100
4,956,800
7,664,700
7,910,700
8,156,300
8,156,3007,910,7007,664,7004,956,8004,357,1003,506,3002,110,2002,073,300
       Other Current Assets 
23,400
611,800
243,700
231,300
232,100
364,200
573,700
10,700
10,700573,700364,200232,100231,300243,700611,80023,400
   > Long-term Assets 
0
9,761,000
12,249,700
15,149,500
16,769,800
17,511,300
17,911,200
18,450,200
18,450,20017,911,20017,511,30016,769,80015,149,50012,249,7009,761,0000
       Property Plant Equipment 
6,854,000
9,211,900
11,065,400
14,233,100
15,829,000
16,296,100
16,474,200
16,981,600
16,981,60016,474,20016,296,10015,829,00014,233,10011,065,4009,211,9006,854,000
       Intangible Assets 
51,400
72,400
74,500
66,500
117,100
107,900
90,200
77,500
77,50090,200107,900117,10066,50074,50072,40051,400
       Long-term Assets Other 
0
400
0
100
0
139,200
65,400
53,200
53,20065,400139,200010004000
> Total Liabilities 
2,971,000
2,800,100
4,072,200
4,509,700
7,198,200
7,830,900
7,912,400
12,910,300
12,910,3007,912,4007,830,9007,198,2004,509,7004,072,2002,800,1002,971,000
   > Total Current Liabilities 
2,598,900
2,466,600
3,460,500
3,776,400
6,061,700
6,486,300
6,473,900
11,392,800
11,392,8006,473,9006,486,3006,061,7003,776,4003,460,5002,466,6002,598,900
       Short-term Debt 
462,500
0
0
333,400
428,500
0
0
0
000428,500333,40000462,500
       Short Long Term Debt 
0
57,700
7,900
353,000
449,400
900
2,700
1,800
1,8002,700900449,400353,0007,90057,7000
       Accounts payable 
0
1,781,800
2,496,300
2,251,800
3,623,400
3,738,600
3,271,700
4,227,700
4,227,7003,271,7003,738,6003,623,4002,251,8002,496,3001,781,8000
       Other Current Liabilities 
0
464,700
676,100
763,900
1,520,600
2,215,800
2,666,800
6,930,600
6,930,6002,666,8002,215,8001,520,600763,900676,100464,7000
   > Long-term Liabilities 
0
316,100
611,700
733,300
1,136,500
1,344,600
1,438,500
1,517,500
1,517,5001,438,5001,344,6001,136,500733,300611,700316,1000
       Long term Debt Total 
148,700
10,400
10,100
6,600
127,100
197,700
185,700
262,000
262,000185,700197,700127,1006,60010,10010,400148,700
       Other Liabilities 
0
323,100
601,600
726,700
1,009,400
1,146,900
1,252,800
0
01,252,8001,146,9001,009,400726,700601,600323,1000
> Total Stockholder Equity
11,908,600
15,676,900
20,413,700
22,452,100
25,988,700
29,956,300
32,643,400
33,879,900
33,879,90032,643,40029,956,30025,988,70022,452,10020,413,70015,676,90011,908,600
   Common Stock
176,900
176,000
176,000
174,500
174,500
173,000
170,800
252,700
252,700170,800173,000174,500174,500176,000176,000176,900
   Retained Earnings 
10,915,600
14,670,300
19,356,700
22,206,900
25,683,600
29,725,600
32,494,700
33,527,500
33,527,50032,494,70029,725,60025,683,60022,206,90019,356,70014,670,30010,915,600
   Capital Surplus 
759,900
760,600
774,200
0
10,600
0
0
0
00010,6000774,200760,600759,900
   Treasury Stock00000000
   Other Stockholders Equity 
53,500
70,000
106,800
70,700
120,000
57,700
-22,100
96,300
96,300-22,10057,700120,00070,700106,80070,00053,500



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue38,679,700
Cost of Revenue-10,845,800
Gross Profit27,833,90027,833,900
 
Operating Income (+$)
Gross Profit27,833,900
Operating Expense-30,644,000
Operating Income8,035,700-2,810,100
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense30,644,0000
 
Net Interest Income (+$)
Interest Income-
Interest Expense-71,600
Other Finance Cost-84,600
Net Interest Income13,000
 
Pretax Income (+$)
Operating Income8,035,700
Net Interest Income13,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)8,653,7008,035,700
EBIT - interestExpense = -71,600
6,601,800
6,673,400
Interest Expense71,600
Earnings Before Interest and Taxes (EBIT)-8,725,300
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax8,653,700
Tax Provision-2,051,900
Net Income From Continuing Ops6,601,8006,601,800
Net Income6,601,800
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--13,000
 

Technical Analysis of AJANTA PHARMA LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of AJANTA PHARMA LTD.. The general trend of AJANTA PHARMA LTD. is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine AJANTA PHARMA LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of AJANTA PHARMA LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2,231 < 2,265 < 2,276.

The bearish price targets are: 2,015 > 2,004 > 1,922.

Tweet this
AJANTA PHARMA LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of AJANTA PHARMA LTD.. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

AJANTA PHARMA LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of AJANTA PHARMA LTD.. The current macd is -11.51065016.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the AJANTA PHARMA LTD. price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for AJANTA PHARMA LTD.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the AJANTA PHARMA LTD. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
AJANTA PHARMA LTD. Daily Moving Average Convergence/Divergence (MACD) ChartAJANTA PHARMA LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of AJANTA PHARMA LTD.. The current adx is 20.63.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy AJANTA PHARMA LTD. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
AJANTA PHARMA LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of AJANTA PHARMA LTD.. The current sar is 2,285.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
AJANTA PHARMA LTD. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of AJANTA PHARMA LTD.. The current rsi is 41.10. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
AJANTA PHARMA LTD. Daily Relative Strength Index (RSI) ChartAJANTA PHARMA LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of AJANTA PHARMA LTD.. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the AJANTA PHARMA LTD. price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
AJANTA PHARMA LTD. Daily Stochastic Oscillator ChartAJANTA PHARMA LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of AJANTA PHARMA LTD.. The current cci is -108.58689688.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
AJANTA PHARMA LTD. Daily Commodity Channel Index (CCI) ChartAJANTA PHARMA LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of AJANTA PHARMA LTD.. The current cmo is -27.94364519.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
AJANTA PHARMA LTD. Daily Chande Momentum Oscillator (CMO) ChartAJANTA PHARMA LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of AJANTA PHARMA LTD.. The current willr is -88.44744455.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
AJANTA PHARMA LTD. Daily Williams %R ChartAJANTA PHARMA LTD. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of AJANTA PHARMA LTD..

AJANTA PHARMA LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of AJANTA PHARMA LTD.. The current atr is 70.49.

AJANTA PHARMA LTD. Daily Average True Range (ATR) ChartAJANTA PHARMA LTD. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of AJANTA PHARMA LTD.. The current obv is -1,149,461.

AJANTA PHARMA LTD. Daily On-Balance Volume (OBV) ChartAJANTA PHARMA LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of AJANTA PHARMA LTD.. The current mfi is 43.88.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
AJANTA PHARMA LTD. Daily Money Flow Index (MFI) ChartAJANTA PHARMA LTD. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for AJANTA PHARMA LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

AJANTA PHARMA LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of AJANTA PHARMA LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.103
Ma 20Greater thanMa 502,156.418
Ma 50Greater thanMa 1002,145.855
Ma 100Greater thanMa 2002,105.423
OpenGreater thanClose2,067.900
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of AJANTA PHARMA LTD. with someone you think should read this too:
  • Are you bullish or bearish on AJANTA PHARMA LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about AJANTA PHARMA LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about AJANTA PHARMA LTD.

I send you an email if I find something interesting about AJANTA PHARMA LTD..


Comments

How you think about this?

Leave a comment

Stay informed about AJANTA PHARMA LTD..

Receive notifications about AJANTA PHARMA LTD. in your mailbox!